MAFFONGELLI, GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 3.881
EU - Europa 322
AS - Asia 216
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 4.423
Nazione #
US - Stati Uniti d'America 3.877
KR - Corea 132
SE - Svezia 59
CN - Cina 57
DE - Germania 57
IE - Irlanda 47
UA - Ucraina 44
IT - Italia 39
GB - Regno Unito 23
RU - Federazione Russa 17
FR - Francia 16
SG - Singapore 15
FI - Finlandia 6
CA - Canada 4
HK - Hong Kong 4
PL - Polonia 4
BE - Belgio 3
KG - Kirghizistan 3
CZ - Repubblica Ceca 2
ES - Italia 2
NL - Olanda 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CL - Cile 1
EU - Europa 1
JP - Giappone 1
SA - Arabia Saudita 1
Totale 4.423
Città #
Wilmington 1.350
Houston 890
Woodbridge 692
Fairfield 185
Chandler 152
Ashburn 81
Seattle 78
Ann Arbor 71
Cambridge 69
Dublin 40
New York 37
Medford 35
Dearborn 30
Beijing 27
Jacksonville 20
Menlo Park 20
Rome 18
Lawrence 17
Singapore 11
San Diego 8
Zhengzhou 7
Hefei 6
London 6
Moscow 5
Palo Alto 5
Hong Kong 4
Kraków 4
Milan 4
Roebling 4
Toronto 4
Brussels 3
Città Sant'Angelo 3
Seoul 3
Shanghai 3
Shenyang 3
University Park 3
Amsterdam 2
Chieti 2
Dong Ket 2
Falls Church 2
Kunming 2
Nanjing 2
Norwalk 2
Olomouc 2
Pomezia 2
Redwood City 2
Saint Petersburg 2
San Jose 2
A Coruña 1
Baotou 1
Boardman 1
Bolton 1
Büdelsdorf 1
Changsha 1
Clearwater 1
Fuzhou 1
Genoa 1
Guangzhou 1
Helsinki 1
Hounslow 1
Kilburn 1
Los Angeles 1
Mountain View 1
Mülheim 1
Nanning 1
Phoenix 1
Pittsboro 1
Redmond 1
Riyadh 1
Rostock 1
Saint Paul 1
San Francisco 1
Sarajevo 1
Sydney 1
Tokyo 1
Wandsworth 1
Xian 1
Totale 3.951
Nome #
Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains 385
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 381
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 367
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group 341
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 328
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 318
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 283
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 273
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 252
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success 236
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy 233
Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report 224
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 202
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? 191
Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir 167
Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards 163
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 122
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 16
Totale 4.482
Categoria #
all - tutte 9.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.490 98 94 72 151 135 143 166 144 149 119 114 105
2020/2021876 97 95 108 104 92 117 94 95 14 28 17 15
2021/2022227 8 16 12 25 16 10 8 7 39 23 15 48
2022/2023326 24 39 39 44 32 52 18 24 38 2 9 5
2023/202490 11 1 3 9 7 23 3 4 6 1 0 22
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 4.482